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Detection, Molecular Typing and Phylogenetic Analysis of 
Leishmania Isolated From Cases of Leishmaniasis among Syrian 
Refugees in Lebanon 
 
By Tamara Salloum  
 
ABSTRACT 
 
Leishmania is a parasitic protozoan with more than two-dozen species causing the disease 
leishmaniasis. It is transmitted to humans through the bite of an infected female 
phlebotomine sand-fly. In the past two years the incidence of leishmaniasis has been 
drastically increasing in Lebanon. This was in parallel with the deterioration of the 
security in Syria forcing thousands to flee seeking shelter at refugee camps in Lebanon. 
Water, sanitation and hygiene facilities in those collective shelters are far from adequate, 
increasing the risk and turning those camps into fertile grounds for the spread of diseases. 
Cutaneous leishmaniasis (CL) is now considered a public health problem, but its 
epidemiology has not been fully elucidated. A crucial point in containing the disease is 
first Leishmania species identification and then correlation with clinical parameters. In 
this study, two molecular typing methods for Leishmania speciation were used along with 
sequencing and phylogenetic analysis. The parasites identified were all Leishmania 
tropica as determined by both the ITS1-PCR RFLP and the nested ITS1-5.8S rDNA gene 
amplification. ITS1-5.8S rDNA gene based typing proved to be more sensitive in the 
detection of parasites (positive in 70% of the isolates) as opposed to the ITS1-PCR RFLP 
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method that was successful in identifying Leishmania in only 47.4% of the isolates. 
Sequencing and phylogenetic analysis revealed high levels of heterogeneity among the 
sequenced isolates. To our knowledge, this is the first study using two different molecular 
methods for the detection and identification of L. tropica in Lebanon. The obtained 
results could be used for accurate detection and diagnosis of Leishmania in CL and for 
tracing possible changes in the population structure of L. tropica.  
 
Key words: Leishmania, Cutaneous leishmaniasis, ITS1, 5.8S rDNA gene, PCR, RFLP, 
Sequence analysis, Lebanon.  
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Chapter One  
INTRODUCTION 
Leishmania is a digenetic parasitic protozoan of the Leishmania genus, family 
Trypanosomatidae and Kinetoplastida order (Ramos et al, 2013). Leishmania parasites 
are transmitted to humans by phlebotomine female sand fly vectors (Teixeira et al, 2013) 
and are the causative agents of leishmaniasis. At least 21 Leishmania species have 
showed to cause disease in humans (WHO, 1990). The disease ranges from localized 
cutaneous leishmaniasis (CL), mucocutaneous leishmaniasis (MCL) to widespread 
visceral leishmaniasis infections (VL), also known as kala-azar, which is fatal if left 
untreated (Tsukamaya et al, 2008; Zhang et al, 2013). It is reported that the disease can 
be both anthroponotic and zoonotic (Ajouad et al, 2013). Signs of localized cutaneous 
leishmaniasis (CL) include papules, crusted nodules, plaques, or nodulo-ulcerative 
lesions. Transepidermal elimination (a skin perforating disorder) is often associated with 
cases of CL (Bolognia et al, 2008), especially with L. donovani (Karram et al, 2012). 
Atypical CL usually does not show these features and thus may be overlooked (Shirian et 
al, 2014). Leishmaniasis is especially aggravated in immune-deficient individuals 
(Nuwayri-Salti et al, 2012). CL is far from being a recent infection. In fact, the 
occurrence of CL has been detected since 2000 BC in Egypt (Oumeish, 1999) and 650 
BC in Assyria (Bray, 1987). VL has been even detected in Egyptian mummies dating 
2050-1650 BC (Zink et al, 2006).   
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The life cycle of Leishmania parasites is fairly complex and usually involves both 
vertebrate and invertebrate hosts. It can be divided into two developmental stages: During 
the first developmental form, Leishmania proliferate in the lumen of a female sandfly 
vector. At this stage they are referred to as promastigotes. During the second 
developmental form, Leishmania occurs as amastigotes and they proliferate inside several 
types of mammalian host cells, including humans. The details of the Leishmania life 
cycle are illustrated in Figure 1 (Teixeira et al, 2013). 
Apart from the usual mode of transmission by the sand fly vector, it has been reported 
that Leishmania parasites can also be transmitted through the placenta (Meinecke et al, 
1999), through sexual intercourse (Symmers et al, 1960), sharing needles (Magill, 1995), 
laboratory acquired infections (Herwaldt et al,1993) and blood transfusions (Dey et al, 
2006). 
 
All Leishmania species that are pathogenic to humans are able to cause cutaneous 
disease, though with varying severities (Van der Auwera & Dujardin, 2015). CL is the 
most common form of leishmanisis with more than 95% of the cases occurring in the 
Americas, the Mediterranean basin, the Middle East and Central Asia especially in the 
following countries:  Afghanistan, Algeria, Brazil, Colombia, Iran (Islamic Republic of) 
and the Syrian Arab Republic. In fact, leishmaniasis is sometimes referred to as “Aleppo 
boil” in the medical literature (Hayani et al, 2014). According to the WHO, it is estimated 
that more than 0.7 million to 1.3 million new cases of CL occur worldwide each year 
whereas an estimated of 200,000 to 400,000 new cases of VL occur worldwide annually 
(WHO, 2014).  Despite these numbers, leishmaniasis is still considered one of the 
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world‟s most neglected diseases with more than 350 million people at risk of contracting 
it (Ramos et al, 2013). 
Some species, such as L. major, generally cause localized self-healing skin lesions. They 
are found in the Mediterranean region, Africa, the Middle East, and further, as far as 
India. Others, such as L. braziliensis, cause severe mutilating mucocutaneous 
leishmaniasis (MCL). They are usually endemic in South America (Reithinger et al, 
2007). L. donovani can also lead to CL. It is mostly endemic in Sri Lanka (Karunaweera, 
2009; Siriwardana et al, 2007). L. infantum (syn., L. chagasi), on the other hand, can lead 
to both CL and VL. It is usually found in Mediterranean countries and Brazil (Singh et al, 
2011). The endemic appearance of L. donovani and L. gerbilli has been recently reported 
in China (Zhang et al, 2013). Similar outbreaks of L. braziliensis have been documented 
as well in South and Central America (Tsukamaya et al, 2008). However, CL cannot be 
always attributed to specific species. For instance, L. braziliensis have been also reported 
to cause mucosal leishmaniasis (ML) in addition to CL (Guerra et al, 2011). Since 
different Leishmania species have been shown to cause CL and due to population travel 
and migration, unexpected Leishmania species can appear in unexpected regions 
(Dujardin, 2006). What‟s more alarming, is that different species show different 
susceptibility to drugs (Blum et al, 2004). Moreover, the parasite has shown primary and 
secondary resistance due to low drug doses, insufficient treatment duration and 
substandard drugs (Desjeux, 2004). It is thus evident that efficient control of 
leishmaniasis, especially CL, requires accurate and fast species typing.  
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Figure 1. Illustration of the life cycle of Leishmania spp. (A), and a detailed structure of the promastigote 
(B) and amastigote (C). In (A), a female sandfly (1) bites an infected person during the blood meal. 
Macrophages become infected and harbor the amastigote form of the parasite (2). Infected macrophages (2) 
with amastigote forms (3). Amastigotes are transformed into procyclic promastigotes (4) that proliferate in 
the midgut of the sandfly (5). Then, they move into the stomodeal valve in the anterior midgut and activate 
cell division (6). Promastigotes now become infective metacyclic promastigotes (7). These are then 
released into a new host following a sandfly bite (8). Metacyclic promastigotes (9) infect macrophages (10) 
and transform into amastigotes (11). These attach to the membrane of the parasitophorous vacuole (12) and 
multiply (13). Following intense amastigote multiplication (14), the cell bursts (15). Some of the 
amastigotes (16) infect macrophages (17). In the central portion of the figure, the most important reservoirs 
involved in the maintenance of the parasite are illustrated. In (B) and (C), the schematic 3D representations 
of the organelles found in the Leishmania promastigote and amastigote are illustrated, respectively 
(Teixeira et al, 2013). 
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The currently available Leishmania classification is not entirely consistent. The main 
problem is due to the fact that some species are so closely related to each other that they 
are often considered to be the same. For instance, L. infantum, L. peruviana, and L. 
panamensis are considered to be subgroups of L. donovani, L. braziliensis, and L. 
guyanensis (Van der Auwera & Dujardin, 2015). 
Another problem that makes species discrimination more difficult is the rare but 
clinically significant occurrence of natural interspecies hybrids (Tojal da Silva et al, 
2006; Nolder et al, 2007; Odiwuor et al, 2011). That is in addition to sexual 
recombination that might be frequent at the intraspecies or population levels (Ravel et al, 
2006). Therefore, proper discrimination at the species level, and sometimes at the sub-
species level as well, is critical for both clinical and epidemiological reasons 
 
Most of the CL Leishmania isolates in the Mediterranean area usually belong to L. 
tropica and L. major  (Schonian et al, 2008; Karram et al, 2012; Yehia et al, 2012). Other 
clinical samples have also shown to be positive for L. infantum (Nakkash-Chmaisse et al, 
2011; Yehia et al, 2012).  Recently, leishmaniasis outbreaks have been reported in a 
number of Lebanese regions (Nakkash-Chmaisse et al, 2011). These coincide with the 
increase in the number of Syrian refugees in several rural areas. Since the beginning of 
the Syrian crisis in 2011, many Syrians have taken refuge in a number of Middle East and 
Gulf countries (UNHCR, 2014). An estimated 1,167,242 Syrian citizens have been 
registered in Lebanon since the beginning of the Syrian war in March 2011 making up 
over a quarter of Lebanon‟s population (UNHCR, 2015). Unofficial numbers suggest a 
count in excess of 2 million people making around 45% of the Lebanese population 
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(WHO, 2014). In 2010, it has been reported that more than 25,000 cases of CL occur in 
Syria yearly (WHO, 2010). Shockingly, these numbers increased to 53,000 cases in 2012 
and 41,000 cases in the first two quarters of 2013 mainly due to the war related living 
conditions, the accompanying migrations of civilians and the lack of appropriate control 
measures (Ministry of Health, Syrian Arab Republic, 2013). Recently, Saroufim et al 
(2014) identified L. tropica in 85% and L. major in 15% out of 948 patients. Other 
studies conducted in Lebanon on 162 patients with CL proved that CL is associated in 
about 30% of the cases with systemic leishmaniasis, which was considered previously to 
be extremely rare (Nakkash-Chmaisse et al, 2011). The number of reported cases of 
leishmaniasis in Lebanon during the years of 2013-2014 and the distribution of 
Leishmania cases in Lebanon are depicted in figures 2 and 3, respectively.  The current 
conditions of the affected individuals include poverty, malnutrition, population migration, 
weakened immunity, poor housing and unsanitary living conditions. All of these factors 
favor the spread of leishmaniasis (Desjeux, 2001). 
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Figure 2. Reported cases of leishmaniasis in Lebanon per month from January 2013 through March 2014. 
Cases have continued to occur in 2014 at a high rate relative to the previous years (2001–2012) (Alawieh et 
al, 2014). 
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Figure 3. Map showing the distribution of Leishmania cases in Lebanon (A). Areas along the Syrian–
Lebanese are the most affected. Map showing the incidence of leishmaniasis among Syrian refugees in 
different regions of Lebanon (B). Bekaa area had the highest incidence (Alawieh et al, 2014). 
 
No absolute correlation between the clinical manifestation of the disease and the 
causative species has been confirmed (Lainson and Shaw, 1998). Thus, accurate 
differentiation of Leishmania and the species and sub-species levels is critical for 
treatment. Detection of Leishmania parasites by PCR amplification has been proven to be 
a rapid, highly sensitive and specific identification method (Garcia et al, 2005). Several 
PCR-based methods have been employed for typing Leishmania parasites. MLEE 
(Multilocus Enzyme Electrophoresis) is considered by many the gold standard for 
Leishmania identification (Banuls et al, 2007; Schonian et al, 2010). DNA sequencing, 
PCR-RFLP (Restriction Fragment Length polymorphism) and MLST (Multilocus 
Sequence Typing) have all been employed for this purpose (da Silva et al, 2010; 
Montalvo et al, 2010; Maiden et al, 1998). However, some genes such as hsp70, proved 
to be too conserved for intra-specific diversity discrimination (da Silva et al, 2010; 
Montalvo et al, 2010). Highly polymorphic markers, such as microsatellites are often 
problematic with taxonomic levels higher than the species, while most other methods 
target multi-copy genes that are often difficult to analyze (Boite et al, 2012). Moreover, 
PCR based methods used for the discrimination of Leishmania parasites are often 
hindered by low sensitivity results that fail to detect amastigotes in samples that proved to 
be positive by microscopy. This caveat in molecular typing methods is often due to a low 
parasite load in the original sample (Shahbazi et al, 2008).  
The long term developmental benefit of typing of the obtained Leishmania species in CL 
is to identify the corresponding isolates with rapid and accurate PCR based methods and 
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trace their epidemiological and evolutionary origins. This allows us to get a better 
understanding of this parasite and have sufficient information for the subsequent 
development of new vaccines or other more efficient preventative methods for the control 
and prevention of leishmaniasis outbreaks. 
 
The objectives of this study are: 
 Identification and typing of Leishmania isolates obtained from Syrian refugees in 
Lebanon using two molecular typing techniques: the ITS1-PCR-RFLP and the nested 
ITS1-5.8S rDNA gene PCR both followed by sequencing and phylogenetic tree 
analysis.  
 Comparing the efficiency of these two techniques in Leishmania identification. 
 Assessing the evolutionary and phylogenetic relationships among these isolates.  
 Assessing the DNA storage in formalin-fixed paraffin embedded (FFPE) tissues by 
evaluating the DNA quality and quantity of the extracted DNA. 
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Chapter Two 
LITERATURE REVIEW 
Different Leishmania species are known to display specific transmission patterns, to 
cause different clinical manifestations and might even have different reactions to 
administered drugs (Arévalo et al, 2007; Romero et al, 2001; Modabber et al, 2007; 
Buffet, 2010). The clinical manifestations of CL are broad and may mimic other 
inflammatory and neoplastic diseases (Saab et al, 2011). Transepidermal elimination was 
also identified in CL (Karram et al, 2012). The immune microenvironment in CL was 
recently evaluated (Jabbour et al, 2014). The choice of treatment is often guided by a 
combination of factors such as the clinical presentation of the disease, the host‟s genetic 
background and immunity, and other confounding factors (Reithinger et al, 2007).  Thus, 
typing and correct identification of the infecting species is critical for accurate and rapid 
diagnosis (Gonzalez et al, 2010). 
2.1. Leishmaniasis in Lebanon 
Only few studies were conducted to evaluate the epidemiology of leishmaniasis in 
Lebanon. Nuwayri-Salti et al (2000) studied the prevalence of leishmaniasis in Lebanon 
between the years of 1993 and 1997 on a population sample of about 81,000 subjects 
(60% rural and 40% urban). They concluded that the prevalence of cutaneous 
leishmaniasis was only 0.18% in the rural versus 0.41% in the urban areas (Nuwayri-Salti 
et al, 2000).  Visceral leishmaniasis was practically non-existent during that time period. 
Moreover, a significant difference was observed between the prevalence of clinical 
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disease and positive skin testing and/or antibodies. It was suggested that this difference is 
due to the presence of past or present subclinical disease. The prevalent Leishmania 
species belonged to the L. donovani complex. All the affected populations were also 
living under the burden of poverty (Nuwayri-Salti et al, 2000). Between 1962 and 1964, 
sporadic cases of VL were recorded in western Lebanon among children under the age of 
10 years (Desjeux, 1991). Later on, parasites escaping the skin and invading the blood 
were detected by Nakkash-Chmaisse et al (2011) where L. infantum was identified in 
most of the studied cases.  
The crisis in the Syrian Arab Republic that started in March 2011 has resulted in outbreaks 
of a large number of previously overlooked diseases in the country itself, as well as in 
neighboring countries including Iraq, Jordan and Lebanon (WHO, 2012). It is now 
certain that environmental changes, including the consequences of climate change, 
agricultural development projects or disasters, and population migrations may affect 
distribution of vector and rodent populations. These changes may favor the parasite 
transmission to new populations, and thus leading to outbreaks (WHO, 2014). It is worth 
mentioning that about 12% of the population in the Eastern Mediterranean countries, 
including Lebanon is living on less than 1 US dollar per day (WHO, 2012). 
Syria is known to have the highest prevalence of CL in the Middle East and North Africa 
(MENA) region (WHO, 2013).  In the literature, it is even referred to as „Aleppo boil‟ 
after the Syrian city Aleppo (McDowell et al, 2011). Recently, due to the massive 
population migrations caused by the ongoing Syrian crisis, new leishmaniasis outbreaks 
have been reported in countries bordering Syria including Turkey, Iraq and Lebanon 
(Sharara & Kanj, 2014; Caglaravci et al, 2013; Alawieh et al, 2014). The United Nations 
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Refugee Agency (UNHCR) has registered around 985 346 Syrian refugees in Lebanon 
with the majority living in the Bekaa and North provinces (62%) (UNHCR; 2013) 
(Figure 3). However, it is reported that the true number of Syrian refugees in the country 
has exceeded one million (Burky, 2013). Facing the increasing risk of the leishmaniasis 
spread, the Lebanese Ministry of Public Health (LMOPH) has implemented active 
surveillance for leishmaniasis since the beginning of the Syrian conflict (Berry et al, 
2013).  
The current leishmaniasis situation in Lebanon in light of the increasing numbers of 
Syrian refugees in the country was evaluated by Alawieh et al (2014). The reported cases 
of infection in Lebanon per month from January 2013 through March 2014 were 
measured as depicted in figure 2 (Alawieh et al, 2014). Another study by Saroufim et al 
(2014) identified L. tropica in 85% (a species endemic to the Aleppo region in Syria) 
and L. major in 15% of 948 cases from a CL outbreak that began in September 2012 
among Syrian refugees in Lebanon (Saroufim et al, 2014). Saab et al (2014) optimized a 
novel method for diagnosis of CL based on drop scrapings. Yehia et al (2012) identified 
L. tropica in 122 skin biopsies using conventional and nested ITS1-PCR. 
An initial cure rate of 82% after 3 months of megulamine antimonite therapy was 
reported among CL patients (Saroufim et al, 2014). So far, no effective vaccine is 
available for Leishmania. Preventation is mainly achieved by limiting exposure to the 
vector through vector control, the use of insect repellents, insecticide-impregnated bed 
nets, and other modalities (Clem et al, 2010; Wang et al, 2012). A lack of evidence in the 
literature for treatment of several leishmaniasis infections is clearly observed (Hodiamont 
et al, 2014). 
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2.2. FFPE tissue storage 
Biopsies of skin lesions that show cutaneous infections, such as leishmaniasis, are usually 
stored in formalin-fixed paraffin-embedded (FFPE) blocks (Ludyga et al, 2012). It is 
generally thought that FFPE tissues can be stable for long periods of time (Abrahamsen et 
al, 2003). They are relatively easy to handle and require a low cost (Kayser et al, 1988; 
Perlmutter et al, 2004). However, the main problem with FFPE is the obvious decrease in 
PCR efficiency due to cross-linking and nucleic acid degradation that increases 
significantly with time, thus yielding low DNA concentrations (Gilbert et al, 2007). 
Oftentimes, the biopsies are taken for histological staining and analysis. The cellular 
composition and features of the pathogen are stable enough to suite this purpose. 
However, DNA starts to degrade the moment the biopsy is taken until it is paraffin fixed 
in a laboratory. This is especially true for Leishmania DNA that has been shown to 
degrade quickly after the death of the parasite (Prina et al, 2007). Moreover, if crosslinks 
are present, negative PCR results can still be obtained despite a high DNA yield, simply 
because the polymerase “falls off” the DNA strand at every crosslink.  Standardized 
techniques for DNA extraction from FFPE are yet to be determined (Ludyga et al, 2012). 
2.3. Criteria for species typing methods 
The search for a universally accepted typing method for Leishmania discrimination has 
been going on for decades (Kirk, 1949). Recently, seven criteria have been designed for 
the purpose of finding an ideal typing tool for the clinical purposes of Leishmania 
identification (Van der Auwera & Dujardin, 2015). First, a species typing tool has to be 
able to discriminate all the variety of Leishmania species available in the studied region. 
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This basic criterion is often overlooked when using new techniques or markers, because 
these are often validated on reference strains not belonging to the studied area. Thus, they 
often give unreliable results (Van der Auwera & Dujardin, 2015). Second, the employed 
typing method should preferably be globally applicable and that is to accommodate all 
the species that might unexpectedly appear in one or more regions around the world 
(Hashiguchi et al, 1991; Katakura et al, 1993; de Oliveira et al, 2009). Third, the assay 
must provide enough sensitivity, especially for typing that starts with culture-independent 
steps. Fourth, the applied testing methods have to be Leishmania specific. This aims to 
avoid any unwanted cross-reactions with other microorganisms that might be co-infecting 
a single patient. This is particularly important in HIV patients in whom several 
trypanosomatids can be encountered (Chicharro and Alvar, 2003) as well as co-infections 
such as mycobacteria and Schistosoma (Bañuls et al, 2007). Fifth, the employed 
technique has to be standardizable. It is easier to standardize a PCR based method than, 
for instance, RFLP where small size differences and incomplete digests may interfere 
with the results analysis. This also proves especially difficult in species-specific PCRs, 
hybridization assays, and melting assays (Van der Auwera & Dujardin, 2015). Sixth, the 
used method has to be only applicable in the setting where it provides the most optimal 
results. And finally, the seventh criterion emphasizes on the fact that the assays used has 
to be validated. This quality check point has to be applied on both Leishmania and non-
Leishmania parasites (Van der Auwera & Dujardin, 2015). 
2.4. An overview of the most commonly used Leishmania typing 
methods 
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During the time period of 1989 to 2007, more than 700 articles on PCR diagnosis of 
Leishmania species have been published in the Pub-Med database. These report a variety 
of gene targets, protocols, and applications and including genus and/or species-specific 
PCR, ranging from low-tech to high-tech approaches (Reithinger & Dujardin, 2007). 
Now, only eight years later, these numbers have almost doubled with more than 1300 
articles available on Pub-Med database. PCR-based assays currently constitute the main 
molecular diagnostic approach for the detection and identification of Leishmania 
parasites in clinical samples (Reithinger & Dujardin, 2007).  
Several methods have been described for Leishmania discrimination in clinical, 
environmental, or cultured samples (Van der Auwera & Dujardin, 2015). Serological 
based testing does not provide enough sensitivity because of the strong Th1 bias. 
Therefore, molecular methods are superior, especially when the parasite load is low 
(Reithinger & Dujardin, 2007). PCR based methods, have targeted different genes to 
suite this purpose. However, in terms of sensitivity and validation, the ITS1 region offers 
the best resolution for Leishmania discrimination in the Old World (Odiwuor et al, 2011). 
The hsp70 and the cytochrome b genes have been found to be globally acceptable as well 
(Folgueira et al, 2007; Alves da Silva et al, 2010; Luyo-Acero et al, 2004). Also, the 
miniexon has shown a sufficient resolution globally speaking, but has a cumbersome 
downstream sequencing (Marfurt et al, 2003). MLEE (Multilocus enzyme 
electrophoresis) is the only method currently available that has been applied to all species 
in epidemiological and environmental studies (Bañuls et al, 2000). So far, no other 
method has been used on the entire Leishmania genus. However, further testing is needed 
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to include species exclusively found in sand fly vectors or animals (Van der Auwera & 
Dujardin, 2015). 
2.4.1. PCR-based typing techniques 
Given the fact that microscopically identifiable parasites are absent in up to 47% of the 
cases, molecular testing for Leishmania has become a reliable diagnostic tool in clinical 
microbiology (Swick, 2012). PCR amplification methods are thought to be highly 
efficient techniques for identification of Leishmania species and these include PCR-
RFLP, PCR-ITS, and RAPD (Random amplified polymorphic DNA) (Ajouad et al, 
2013).  Other methods are also available such as multilocus enzyme electrophoresis 
(MLEE), which is thought to be costly and time consuming (Zemanova et al 2006), 
multilocus microsatellite typing (MLMT) and multilocus sequencing typing (MLST) 
(Tsukamaya et al, 2008). When applying any of the above mentioned methods, it is 
important to consider the level of resolution targeted by each of these techniques. If a 
specific marker detects too much variation, an accurate representation of distantly related 
species will not be achieved and useful traits might be overlooked. On the other hand, if a 
marker does not provide enough variability, it will fail to discriminate closely related 
isolates (Schonian et al, 2011).  
Leishmania parasites contain only 10
-13
 g of DNA, meaning that 10 million parasites 
would be required to generate 1 ug of workable DNA (Barker, 1989). This makes gene 
detection in Leishmania isolates extremely difficult. In order to obtain sufficient amount 
of DNA for further analysis, the process of DNA extraction has to be critically efficient.  
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Mouttaki et al (2014) demonstrated that 13A/13B primers targeting kinetoplast DNA 
(kDNA) were able to detect 0.1 pg of leishmanial promastigote cells per PCR tube and 
thus were significantly more efficient than other reported primers. This may be explained 
by the fact that Leishmania promastigotes contain approximately 10,000 copies of the 
kDNA target which is 50 and 250 fold higher than ITS1 target regions (40 to 200 copies) 
(Mouttaki et al, 2014). Anders et al (2002) found that the Lmj4/Uni21 PCR, also 
targeting kinetoplast DNA (kDNA), could detect 0.25 parasites. Ajouad et al (2013) 
reported that nested PCR of the ITS1-5.8S rDNA region allowed the detection of 1pg/uL 
of DNA as opposed to the ITS1-PCR method that detected 10 pg/uL of extracted DNA. 
Hence, the observed differences in sensitivity can be due several variable parameters 
within the PCR assays such as the quality of the clinical samples, the DNA extraction 
method that largely determines the obtained DNA quality and quantity and finally, the 
Taq polymerase used as well (Anders et al, 2002).  
2.4.2. rDNA array 
Ribosomal DNA (rDNA) array has been found to be one of the most efficient species 
typing targets. In fact, 10 to 20 copies of rDNA are tandemly repeated per haploid 
genome of Leishmania. Additionally, each repeat unit consists of several genes and 
spacers (Martinez-Calvillo et al, 2001; Inga et al, 1998). Within the array, primarily the 
spacer regions provide enough variability for species discrimination. They have also been 
reported to be used for discrimination at the subspecies level (Schönian et al, 2000; 
Schönian et al, 2001; el Tai et al, 2000). Thus, ITS-PCR is often used in molecular typing 
because ITS (rRNA internal transcribed spacers) are subjected to less evolutionary 
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pressure and thus show more sequence divergence than other coding regions in the 
genome (Almeida et al, 2011). 
Large amount of evidence has proven that the ITS region in Leishmania consists of at 
least two alleles. A study conducted by Ghatee et al (2013) revealed a 100 bp gap in the 
ITS sequences of L. tropica isolated from Iran. The entire ITS1-5.8S-ITS2 sequence in 
rDNA was amplified using LITSV and LITSR primers. The additional 100 bp fragment 
was then excluded by designing new primers: LITSR and LITS-MG (Ghatee et al, 2013). 
Also, Mauricio et al (2004) reported at least two alleles in ITS of L. tropica based on 
RFLP fragments size that showed to be larger than the actual amplification product. 
The difference in the alleles of the ITS sequence proposes possible recombination in L. 
tropica. In fact, recombination has been previously detected in the ITS region. For 
instance, the enzyme (N-Acetyl Glucosamine-1-Phospate Transferase) was subjected to 
recombination in L. tropica (Waki et al, 2004). The presence of significant heterogeneity 
and genetic variation in some Leishmania species, mainly in L. tropica (Shonian et al, 
2001) strengthens the hypothesis of both recombination and sexual reproduction. This 
might have a major influence on drug resistance and pathogenicity in these isolates. 
2.4.3. Available primers 
Different studies use different sets of primers that flank various regions within the ITS. A 
list of the used primers that target the ITS region in Leishmania is summarized in table 
1(Guerbouj et al, 2014). For instance, the primer pair L5.8S and LITSR has been used to 
target the entire ITS-1 region (Schonian et al, 2003) while the primers IR1 and IR2 
followed by nested PCR using ITS1F and ITS2R4 target the ITS1-5.8S rDNA gene 
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region (Figure 4) (Ajouad et al, 2013; Parvizi et al, 2005; Parvizi et al, 2008; Cupollilo et 
a, 1995).  
 
Figure 4. Schematic representation of the different  ITS regions covered by primers in nested-PCR in 
Leishmania. SSU=small subunit gene, LSU= large subunit gene (Parvizi et al, 2008). 
2.4.4. ITS1-PCR 
ITS1 region is located between the 18S rRNA and 5.8S rRNA genes (Cupollilo et al, 
1995). The major advantage of using the ITS1-PCR typing method for species 
identification is that the obtained PCR amplicons can be further digested and 
distinguished by RFLP. However, several studies have concluded that ITS1-PCR 
followed by RFLP does not provide enough sensitivity to accurately diagnose cases of 
leishmaniasis (Schonian et al, 2003; Bensoussan et al, 2006; Azmi et al, 2011). Thus, 
nested ITS1-5.8S rDNA gene PCR showed to provide better means for species 
discrimination (da Silva et al, 2013; Ajouad et al, 2013; Parvizi et al, 2008; Yehia et al, 
2012). Also, high-resolution melting analysis has been developed based on a 265- to 288-
bp fragment within ITS1 (Talmi-Frank et al, 2010). Following PCR, the temperature at 
which both DNA strands separate was recorded, and this temperature was found to be 
species specific. Similar to the results obtained from RFLP analysis, the Old World 
species were all distinguishable, with the exception of L. infantum from L. donovani. 
Spanakos et al (2008) depicted the use of sequencing, RFLP, and single-strand 
conformation polymorphisms for species discrimination in the Old World. They focused 
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on a specific ITS1 fragment that largely overlaps the LITSR-L5.8S region. They found 
the same level of species discrimination as provided by the LITSR-L5.8S region but these 
methods were not as extensively validated (Spanakos et al, 2008). Other examples based 
on ITS1 sequencing include the studies performed by Parvizi and Ready. They also used 
primers covering the LITSR-L5.8S target. But their fragment extended into the 5.8S 
rDNA gene. However, this did not show any advantage for species identification (Parvizi 
and Ready, 2008). Others further extended this region into the small-subunit (SSU) 
rRNA. This strategy achieved typing of Leishmania species in the New World by RFLP 
analysis, but failed to discriminate all species and all complexes (Rotureau et al, 2006).  
2.4.5. ITS2 typing 
Several studies covering the either the ITS2 region or both the ITS1 and the ITS2 regions 
have been reported (Cupolillo et al, 1995; de Almeida et al, 2011). PCR-RFLP analysis 
of a fragment covering both ITS1 and ITS2 proved to be successful in identifying all 
tested species of the Leishmania (Viannia) (Cupolillo et al, 1995). However, the main 
problem with this strategy is that it requires 10 enzymes for DNA product digestion and 
sequencing proved to be cumbersome due to microsatellite regions in ITS2 (Parvizi  and 
Ready, 2008). Recently, Almeida et al reported an ITS2-based assay that could 
successfully separate three tested Leishmania (Viannia) species (de Almeida et al, 2011). 
Since targeting the ITS2 region did not show any noticeable advantage over ITS1, it has 
been less used and evaluated. However, it might be useful in complementing the ITS1 
region for discriminating species of the Leishmania (Viannia) subgenus (Van der Auwera 
& Dujardin, 2015). 
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2.4.6. Nested PCR 
Nested PCR is a modification of conventional PCR that aims to reduce non-specific 
binding on the DNA template that might arise due to the erroneous amplification of 
unexpected primer binding sites. For this purpose, nested PCR involves two sets of 
primers, used on two successive PCR runs, where the second set of primers binds to and 
amplifies a more specific region located internally to the first run product (Figure 4) 
(Parvizi et al, 2008).  Nested PCR provides a sensitive and specific alternative to 
traditional techniques used for Leishmania identification (Akahavan et al, 2010). 
Although often tedious and time-consuming, nested PCR has been widely employed in 
Leishmania identification methods (Parvizi et al, 2008; Schonian et al, 2006). This aims 
to overcome the problems of low DNA concentrations usually observed in Leishmania 
parasite samples and to enhance the sensitivity of subsequent PCR-based analysis 
(Ajouad et al, 2013). Nested ITS1-5.8S rDNA gene PCR provided enough sensitivity for 
the discrimination of most clinically relevant Leishmania species (da Silva et al, 2013; 
Ajouad et al, 2013; Parvizi et al, 2008; Yehia et al, 2012).   
2.4.7. RFLP 
One of the most widely used techniques for speciation and sub-speciation of Leishmania 
isolates is RFLP (restriction fragment length polymorphism) analysis. Here, the PCR 
product is digested with one or several restriction endonucleases and generates differently 
sized DNA fragments. The sizes of the obtained bands allow identification of the parasite 
(Van der Auwera & Dujardin, 2015).  HaeIII restriction enzyme is the most commonly 
used. However, it does not allow the discrimination of members of the L. donovani 
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complex (L. donovani and L. infantum) nor the L. braziliensis complex (L. braziliensis, L. 
guyanensis etc.) because these show almost identical RFLP profiles (Schonian et al, 
2003; Morales et al, 2001). In the New World, the gene encoding the heat shock protein 
of 70 kDa (hsp70) has been used as a target for PCR-RFLP (Garcia et al, 2004).  Also, 
Hsp70 PCR-RFLP with different restriction endonucleases has been employed for 
identiﬁcation of Old World and New World Leishmania species (Fraga et al, 2010; 
Montalvo et al, 2010; Khanra et al, 2012). 
2.4.8. Sequencing analysis 
A more informative method is the sequence analysis of the PCR amplicon. The 
subsequent identification of single-nucleotide polymorphisms (SNPs) or comparison of 
the obtained sequence with available reference sequences allows for species identification 
and tracking of evolutionary relationships among the sequenced isolates (Van der 
Auwera & Dujardin, 2015).  In comparative sequence analysis, it is crucial to select 
appropriate reference sequences which are often difficult to find because recently it has 
been shown that several species designations in the public databases are in fact erroneous 
(Van der Auwera et al, 2013). Thus, as it was performed in this study, a combination of 
different assays provides more information for species discrimination and thus decreases 
the chance of errors. 
 
In this study two molecular typing methods are performed for the detection and 
identification of Leishmania parasites in cases of cutaneous leishmaniasis. First the FFPE 
storage method is assessed and then for species identification the ITS1-PCR RFLP and 
the nested ITS1-5.8S rDNA gene PCR followed by sequencing and phylogenetic analysis 
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are performed. Finally, to rule out that the observed variability between the two 
techniques is not due to DNA quality, DNA quality assessment is conducted. 
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Chapter Three 
MATERIALS AND METHODS 
 
3.1. Sample collection and description: 
A total of 40 FFPE blocks were obtained from the American University of Beirut 
Medical Center in Lebanon. FFPE blocks contained skin biopsies from patients suspected 
of having cutaneous leishmaniasis during the years of 2013-2014. Each patient had one 
biopsy performed, and one FFPE block per biopsy was available. Cases included in the 
study were restricted to cutaneous lesions of patients who did not receive treatment prior 
to the biopsy. Clinical information pertaining to the lesion was also collected including: 
number, duration, location and dermatologic appearance. In addition, the patient‟s age, 
gender and country of residency were tabulated (Figure 5, Figure 6, Annex I). Organisms 
collected from cultures were used as positive controls to validate the analysis. IRB 
approval was granted prior to the initiation of this study (PALM I.K.01).  
3.2. Histopathology 
Sections from each of the 40 FFPE tissue blocks were previously stained for hematoxylin 
and eosin, Giemsa, Acid Fast bacilli, Gomori Methylamine Silver and Periodic Acid-
Schiff. All cases were reviewed by four pathologists (JS, RK, FF and IK) and classified 
according to the modified Ridley‟s parasitic index (Table 1 and Figure 7). 
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Table 1. Modified Ridley‟s parasitic index. 
 
3.3. DNA Extraction 
Eight 10 μm ribbons were obtained from each FFPE block. Then 400 μL of cell lysis 
solution (Qiagen Gmbh, Hilden, Germany) and 1.5 μL of proteinase K were added 
(Fermentas, Canada). Excess paraffin was trimmed off. After brief vortexing, the samples 
were incubated overnight at 65°C. After incubation, the tubes were centrifuged at 13,000 
g for 10 min. A paraffin layer formed at the top of the tube. With a pipette, the layer was 
gently punctured and the liquid aspirated and transferred to a new autoclaved 1.5 ml 
microcentrifuge tube. The samples were then cooled on ice for 1 min and 133 μL of 
protein precipitation solution (Qiagen Gmbh, Hilden, Germany) were added. This was 
followed by vortexing for 20 sec and leaving the samples on ice for 30 min. The samples 
were then centrifuged at 20,000 g for 10 min. Supernatant was transferred to a new 1.5 
mL microcentrifuge tube and 400 μL of 100% isopropanol and 1 μL of glycogen solution 
(Qiagen Gmbh, Hilden, Germany) were added. After centrifugation for 15 min at 20,000 
g, the DNA appeared as a white pellet. 200 μL of 70% ethanol were added to the pellet 
and then centrifuged at 20,000 g for 10 min. 
The supernatant was poured off and the sample dried at room temperature for 
approximately 10 min. Finally, 30 μL of Elution Buffer (Qiagen Gmbh, Hilden, 
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Germany) were added and the tube incubated at 50°C for 30 min with vigorous vortexing 
every 10 min. The resultant DNA was then quantified with NanoDrop ND-100 
spectrophotometer and Qubit fluorometer (Thermo Fisher Scientific, USA) and stored at 
4°C for subsequent PCR analysis. 
3.4. ITS1 PCR of Leishmania isolates 
The extracted DNA from FFPE blocks were examined for the Leishmania-specific 
ribosomal ITS1 region by PCR amplification using L5.8S and LITSR primers followed 
by RFLP analysis. The volume of DNA to be amplified was calculated to normalize the 
quantity among all isolates. 5 uL of DNA was used for ITS1 gene amplification in a 50 
uL total reaction volume. A master mix was prepared consisting of 0.2 mM dNTPs, 1 X 
Taq buffer, 1.5 mM MgCl2, 500 nM of both the forward and the reverse primers and 2 U 
of Hot-Start Taq Gold DNA polymerase. The cycling conditions were 95°C for 12 min 
followed by 32 amplification cycles, each consisting of three steps: denaturation at 94°C 
for 20 sec, annealing at 53°C for 30 sec and extension at 72°C for 1 min, followed by a 
final extension at 72°C for 6 min in the thermocycler. All polymerase chain reaction 
(PCR) assays were performed on a PerkinElmer GeneAmp 9700 thermal cycler 
(PerkinElmer, Wellesly, Massachusetts). 
Nested PCR was performed on all isolates that were negative by conventional PCR. 10 
uL of the ITS1 PCR amplicon were amplified in a 50 uL total reaction volume using the 
same primers and the same cycling conditions.  
PCR amplicons were analyzed by 1.5% agarose gel electrophoresis (1.5% TAE gels 
stained with ethidium bromide). 25 uL of loaded PCR products were electrophoresed at 
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90 V in 1X TAE buffer (400mM Tris-acetate, 10mM EDTA, pH: 8.2–8.4) and compared 
to a standard 100 bp DNA ladder. A DNA band of 300-350 bp was considered as a 
positive indicator for the presence of Leishmania.  
Table 2. The primers used in this study, their corresponding sequences and target amplicon size. AS, 
antisense primer; ITS1, internal transcribed spacer 1; PCR, polymerase chain reaction; S, sense primer. 
 
Targeted 
Gene 
Primer Sequences 
Amplicon 
size 
LITSR 5‟-CTGGATCATTTTCCGATG-3‟ 300-350 bp 
L5.8S 5‟-TGATACCACTTATCGCACTT-3‟  
IR1 
5‟-
GCTGTAGGTGAACCTGCAGCAGCTGGATCATT-
3‟ 
320 bp 
IR2 
5‟-GCGGGTAGTCCTGCCAAACACTCAGGTCTG-
3‟ 
 
ITS1F 5‟-GCAGCTGGATCATTTTC-C-3‟ 400 bp 
ITS2R4 5‟-ATATGCAGAAGAGAGGAGGC-3‟  
Actin S 5‟-CGC TGC GCT GGT CGT CGA CA-3‟ 
600 bp 
 AS 5‟-GTC ACG CAC GAT TTC CCG CT-3‟ 
 
GAPDH S 5‟-TGGTGCTCAGTGTAGCCCAG-3‟ 
110 bp 
 AS 5‟-GGACCTGACCTGCCGTCTAG-3‟ 
 
 
3.5. RFLP 
10 uL of the obtained PCR products were digested with 2 uL of the restriction 
endonuclease BsuRI (HaeIII) in 2 uL of 10X Buffer R (Thermo Fisher Scientific, USA) 
(1X of buffer R consists of 10 mM Tris HCl (pH 8.5 at 37°C), 10 mM MgCl2, 100 mM 
KCl, 0.1 mg/mL BSA) and 18 uL H2O. The samples were mixed gently and spun down.  
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Digestion was performed in a thermal cycler, in a total reaction volume of 32 uL, with the 
following conditions: 6h at 37° C followed by 20 min at 80°C. 25 uL of the PCR product 
were run on 2.5% agarose gel in 1X TAE (0.04M Tris-acetate, 1mM EDTA, pH=8) for 1 
h. The obtained bands were compared to 100bp and 20 bp ladders.  
3.6. Nested PCR of ITS1-5.8S rDNA genes of Leishmania isolates 
The previously extracted DNA was further screened for infection with Leishmania by 
targeting the ITS1-5.8S rDNA gene region. This step consisted of two stages of 
amplification:  The first was performed using the forward IR1 and the reverse IR2 
primers, while the second was performed with the nested-forward ITS1F and the nested-
reverse ITS2R4 primers (Table 1). In the first stage of amplification: A total reaction 
volume of 20 μl was prepared of 1X PCR reaction buffer, 1.5 mM of MgCl2, 60 μM of 
each dNTP, 1 μM of IR1 and 1 μM of IR2 primers, 1 U of Taq polymerase and 2 uL of 
the template DNA. PCR was performed under the following conditions: initial 
denaturation at 95°C for 12 min followed by 39 cycles consisting of denaturation at 94°C 
for 30 sec, annealing at 58°C for 30 sec and extension at 72°C for 90 sec. The extension 
step was further continued for 10 min after the last cycle. 
In the second stage: The products obtained from the first PCR were further amplified by 
the nested-PCR technique. A total reaction volume of 20 μl was prepared consisting of 
1X PCR reaction buffer, 1.5 mM of MgCl2, 60 μM of each dNTP, 1 μM of ITS1F and 1 
μM of ITS2R4 primers, 1 U of Taq polymerase and 2 μL of the previously obtained PCR 
product. PCR was performed under the same conditions as the 1
st
 stage of amplification. 
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The obtained band were electrophoresed on a 1.5% agarose gel in 1X TAE buffer and 
compared to a 100 bp ladder. 
3.7. PCR Product Purification 
The obtained PCR products of both PCR reactions, targeting the entire ITS1 and the 
ITS1-5.8S rDNA gene regions, were purified using ExoSAP-IT (Thermo Fisher 
Scientific, USA). 
3.8. DNA Sequencing Reaction 
The amplicons were sequenced using the ABI Prism BigDye Terminator v3.1 Cycle 
Sequencing Kit (Applied Biosystem, USA). Two sequencing reactions were performed 
for each isolate. The sequencing reaction consisted of the BigDye premix, 0.2 pmol of 
either forward or reverse primer, and the cleaned PCR product in a total volume of 10 μl. 
The same primers used in the PCR were used for sequencing. All sequencing reactions 
were performed with 25 cycles of 96 °C for 10 sec, 50 °C for 5 sec, and 60 °C for 4 min. 
PCR products were sequenced by Genetic Analyzer 3500 (Life Technologies, USA) 
using the BigDye XTerminator purification kit (Applied Biosystems, USA).   
3.9. Sequence Analysis and Phylogenetic Tree 
Sequences obtained were analyzed on CLC Main Workbench V3.1 (CLC BIO, Denmark) 
software. Sequences were aligned and a phylogenetic tree was constructed using the 
Neighbor-Joining algorithm in CLC Main Workbench v.7.0.3 and bootstrap values for 
100 replicates were indicated.  
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Sequences obtained from both procedures were compared to seven references extracted 
from NCBI BLAST (Accession numbers: KJ567476, KJ567477, KJ567478, KJ567479, 
KJ567480, KJ567481 and KJ567482). References used cover the ITS 1, partial sequence; 
5.8S rRNA gene, complete sequence and the ITS 2, partial sequence (Table 4).  
Table 3. The sizes and G+C content of the reference samples included in the phylogenetic trees. 
References were extracted from NCBI BLAST. References used cover the ITS 1, partial sequence; 5.8S 
rRNA gene, complete sequence and ITS 2, partial sequence. 
 
Reference Size (bp) 
G+C content 
(%) 
GenBank accession 
no. 
L. tropica 390 44.10 KJ567476  
L. tropica 390 44.36 KJ567477  
L. tropica 390 44.10 KJ567478 
L. tropica 390 45.90 KJ567479 
L. infantum 391 43.73 KJ567480 
L. infantum 392 43.62 KJ567481 
L. infantum 392 43.88 KJ567482 
 
3.10. DNA quality assessment 
In order to assess the DNA quality of the extracted DNA, Actin and GAPDH 
amplification were performed under the following conditions: A total reaction volume of 
50 uL was prepared consisting of 0.2 mM dNTPS, 1 X Taq buffer, 1.5 mM MgCl2, 500 
nM of both forward and reverse primers and 2 U of Taq DNA polymerase. For actin, 10 
uL of DNA were amplified under the following cycling conditions: initial denaturation at 
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95°C for 12 min followed by 35 cycles consisting of denaturation at 94°C for 20 sec, 
annealing at 56°C for 30 sec and extension at 72°C for 1 min. Followed by a final 
extension step of 72°C for 10 min. For actin, 10 uL of DNA were amplified under the 
following cycling conditions: initial denaturation at 95°C for 12 min followed by 40 
cycles consisting of denaturation at 94°C for 20 sec, annealing at 60°C for 30 sec and 
extension at 72°C for 1 min. Followed by a final extension step of 72°C for 10 min.  
25 uL of the obtained PCR product were loaded on a 1.5% agarose gel and compared to a 
100 bp and a 20 bp ladders. 
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Chapter Four 
RESULTS 
 
4.1. DNA Extraction  
Skin biopsies from 40 patients from Lebanon and Syria with clinical diagnosis of 
suspected cutaneous leishmaniasis were assessed. The specimen was obtained by either 
shave or punch biopsy, and the duration of the lesions ranged from 1 to 12 months (mean: 
4.61 ± 2.36 months). 
Ages of patients varied from 1 to 83 years (mean: 25.90 ± 23.22 years). 57.5% of patients 
were females and 42.5% were males (Figure 5). Most of the samples (37.5 %) were from 
the 0-10 years old age group followed by the above 60 years old age group (22.5 %) 
(Figure 6).  
 
Figure 5. Distribution of male and female cases of leishmaniasis among different locations of sample 
collection. Location include Beirut, Zahle, Akkar, Saida and Aleppo. The highest number of leishmaniasis 
cases was reported in Beirut; Male and female cases had an equal occurrence.   
B 
C D 
A B 
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Figure 6. Distribution of cases of leishmaniasis among different age groups and locations. The graph 
shows that the highest frequency of cases occurred in the younger age groups (<10 years old) followed by 
the oldest age group (> 60 years old).  
 
Of the 40 skin biopsies, microscopic evaluation of stained slides identified about 17 cases 
(42.5%) showing a parasitic index of 0–1+ and labeled as microscopically negative (with 
no unequivocal amastigotes detected) (Figure 7). 
 
Figure 7. An illustration of (A) parasitic index 6, (B) parasitic index 5, (C) parasitic index 4 and (D) 
parasitic index 0 (Yehia et al, 2012). 
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Figure 8. Chart showing a summary of the procedures conducted and a summary of the results 
obtained. 
 
Following extraction, the obtained DNA concentrations ranged from 8.5 ng/uL to 462.3 
ng/uL (66.16 ± 99.62 ng/uL) as measured with the NanoDrop ND-100 spectrophotometer 
and with a purity ranging from 1.25 ng/uL to 7.24 ng/uL (2.03 ± 1.11). The Qubit 
fluorometer (Thermo Fisher Scientific, USA) revealed DNA concentrations ranging from 
0.2 ng/uL to 28.5 ng/uL (4.34 ± 0.29 ng/uL) (Annex II). 
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4.2. Leishmania genotyping 
The first step of genotyping was to identify the Leishmania species. For this purpose, 
ITS1 PCR-RFLP was performed. The second step by nested PCR of ITS1-5.8S rDNA 
gene region allowed enhancing the sensitivity of the results. A comparison of these two 
methods was performed accordingly. 
4.2.1. ITS1 PCR of Leishmania isolates 
None of the isolates were positive for the first PCR step targeting the ITS1 region, using 
the LITSR and L5.8S primers (Table 5). After performing nested PCR on all isolates 
using the same primers, 18 out of 38 isolates (47.4%) produced a band at around 350 bp. 
Figure 9 shows a comparison between loading volumes of either 10 uL or 25 uL below 
for two isolates followed by a negative control. Loading 25 uL of the PCR product 
yielded significantly sharper bands. 
 
 
Figure 9. Nested internal transcribed spacer 1 polymerase chain reaction (ITS1-PCR). Agarose gel 
electrophoresis of the amplicons of ITS1-PCR for two representative isolates obtained after nested PCR 
300 bp   
10 uL  
400 bp   
400 bp   
300 bp   
10 uL  N  25 uL  25 uL  N  
A B 
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using the same primers (A). 10 uL of the PCR amplicon were loaded on the gel. The gel revealed two 
positive specimens that showed a DNA band between 300 and 350 bp. Agarose gel electrophoresis of the 
same two isolates positive for Leishmania. 25 uL of DNA were loaded on the gel (B). Thicker bands were 
observed between 300 and 350 bp. A 100 bp ladder was used as a molecular marker. N: negative control. 
 
Table 4. A list of the isolates that gave a positive ITS1-PCR band and that were subsequently used for 
RFLP. Sequencing resulted in the following sizes and G+C content.  
 
 Biotype Isolate Name Size (bp) G+C Content (%) 
1 HH-13-10 L1 279 53.05 
2 HH-13-11 L2 289 38.06 
3 HH-13-12 L3 262 41.22 
4 HH-13-14 L4 138 44.93 
5 HH-13-16 L5 185 53.43 
6 HH-13-17 L6 284 39.44 
7 ZA-13-5 L7 91 52.75 
8 ZA-13-6 L8 141 46.10 
9 AK5 L15 289 40.48 
10 1-HH L16 278 44.60 
11 4-HH L17 289 41.87 
12 S13-60-1A L18 277 40.07 
13 S13-193-1A L19 287 35.54 
14 AK13-13 L20 273 38.46 
15 D02-727A L24 287 42.51 
16 D04-228 L26 90 52.22 
17 D10-533 L34 123 50.4 
18 D94-270 L43 90 40 
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4.2.2. RFLP 
The digestion of the PCR product with endonuclease HaeIII revealed the profiles of L 
.tropica consisting of two bands (200 bp and 60 bp). Most of the bands obtained appeared 
faint. 
 
 
 
Figure 10. Results of Restriction Fragment Length Polymorphism (RFLP). RFLP pattern typical for 
Leishmania tropica showing two restriction fragments of 200 and 60 basepair (bp) obtained after digestion 
of representative internal transcribed spacer 1 polymerase chain reaction (ITS1-PCR) with the restriction 
enzyme HaeIII. 100 bp and 50 bp ladders were used as molecular marker. N: negative control. 
4.2.3. Sequencing and Phylogenetic tree analysis 
Sequences showed a size range of 90 to 289 bp (average: 219.55 ± 82.62 bp) and a G+C 
content ranging from 35.54% to 53.43% (average: 44.17 ± 5.83%). Alignment of the 18 
sequences revealed a percent conservation of 6% to 94% (average: 50.85 ± 19%) per 
nucleotide. Alignment showed three different sequence types. These three types included: 
sequences L1-L6, L8, L15-L20 and L24 that showed significant similarity but with 
N  L1  L2   L3   L4  L5  L6  L7  L8  
200 bp   
50 bp   
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several point mutations; sequences L7, L26 and L34 that appeared to have several 
common regions and L43 that showed to be distantly related to the other sequences. The 
phylogenetic tree revealed that L7, L26 and L43 clustered together (Clade II) while L34 
appeared to be more closely associated to the references (Clade III) than to the other 
isolates. Regarding the G+C content, L7, L26 and L34 appeared to have significantly 
higher G+C contents than the other isolates (52.75%, 52.22% and 50.4% respectively) 
while the G+C content of L43 was 40%.  
The aligned sequences showed several blocks of conserved nucleotides in addition to a 
high occurrence of polymorphisms and variations (Figure 11). Variation was reflected by 
the low bootstrap values obtained. For instance, a block of 13 conserved nucleotides 
(GCTTTATGTGAGC) was observed at position 40 with T→G change at position 43 in 
L5 and A→G at position 51 in L8. Another 8 consecutive conserved nucleotides 
(ACCCCCCC) were observed in all the obtained sequences, except for L1, L4, L5, L34 
and L43, at position 70. In L26, AC→GG at position 70 was observed. Another 17 
nucleotides were conserved at position 230 (TATAAAAAGTCTCCGCA) in all isolates 
except for L4, L5, L7, L8, L34 and L43. T→A was observed in L17 at position 230 and 
AAA→TTT in L18 at position 233.  
Phylogenetic analysis based on the partial sequence of the ITS1 rDNA gene separated the 
isolates into four distinct clusters (Figure 12). Sequences were compared to L. tropica 
and L. infantum references retrieved from GenBank with the following accession 
numbers: KJ567478, KJ567477, KJ567476, KJ567479, KJ567481, KJ567480 and 
KJ567482. The references covered ITS1 partial sequence, 5.8S rDNA gene complete 
sequence and ITS2 partial sequence. Cluster I, included L3, L6 and L18, cluster II was 
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composed of L7, L5, L26, L4, L8, L43 and L1, cluster III consisted of all the above 
mentioned references, in addition to L34 and L20 and finally, cluster IV consisted of L2, 
L16, L24, L15, L19 and L17.  
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Figure 11. ITS1-PCR RFLP gene sequences alignment of L. tropica isolates using CLC Main Workbench v3.1. 
Matching residues are depicted as dot and highlighted with the same color. Gaps are denoted as dashes.   
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4.3. Nested PCR for amplifying the ITS1-5.8S rDNA gene of Leishmania 
isolates 
40 isolates were screened for Leishmania infection by nested PCR. The first PCR 
reaction using the ITS1 and ITS2 primers showed no bands on gel electrophoresis. The 
nested PCR reaction produced bands at around 400 bp for 28 isolates (70%).   
 
 
Figure 13. Nested-PCR of ITS1-5.8S rDNA gene of Leishmania DNA. Agarose gel electrophoresis of 
representative isolates positive for Leishmania give a DNA band around 400 bp characteristic of L. tropica. 
100 bp ladder was used as a molecular marker. N: negative control. 
 
Table 5. A list of the isolates that gave a positive band after nested ITS1-5.8S rDNA gene PCR. 
Sequencing resulted in the following sizes and G+C content. GenBank accession numbers were obtained.  
 Biotype Isolate Name Size (bp) 
 
G+C Content (%) 
 
100 bp  
L1 L2 L3 L4 L5 L6 L7 N 
L13 L15 L16 L17 L18 L19 L20 N 
400 bp  
100 bp  
400 bp  
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1 HH-13-10 L1 440 22.5 
2 HH-13-11 L2 435 34.47 
3 HH-13-12 L3 438 37.67 
4 HH-13-14 L4 436 38.30 
5 HH-13-16 L5 439 39.86 
6 HH-13-17 L6 436 42.89 
7 ZA-13-5 L7 435 40.69 
8 ZA-13-6 L8 512 49.41 
9 ZA-13-8 L9 429 45.22 
10 ZA-13-10 L10 435 42.76 
11 ZA-13-11 L11 441 38.55 
12 ZA-13-13 L12 405 45.43 
13 AK1 L13 428 39.72 
14 AK2 L14 410 39.27 
15 AK5 L15 439 39.18 
16 1-HH L16 435 40.23 
17 4-HH L17 436 39.68 
18 S13-60-1A L18 430 35.11 
19 S13-193-1A L19 429 52.11 
20 AK13-13 L20 254 46.46 
21 D02-727A L24 439 37.13 
22 D02-727B L25 434 39.17 
23 D04-228 L26 432 40.05 
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24 D05-536 L27 435 41.61 
25 D08-154 L29 440 41.82 
26 D08-1029 L30 422 37.68 
27 D08-1030 L31 439 36.90 
28 D10-533 L34 436 41.28 
 
4.3.1. Sequencing and Phylogenetic tree analysis 
Alignment revealed a high level of conservation with the presence of single point 
mutations. Analysis of the ITS1-5.8S rDNA gene sequences further confirmed that they 
all belonged to L. tropica. Sizes ranged from 71 bp to 512 bp (average: 416.46 ± 77.83 
bp) and the G+C content ranged from 22.5% to 52.11% (average: 40.18 ± 5.28%).  
In general a high level of conserved nucleotides was observed between the sequenced 
isolates and the reference strains.  Percent conservation ranged from 4% to 100% (as per 
every nucleotide) (mean= 62.5% ± 29.75%). 
Alignment revealed that blocks of conserved nucleotides start appearing at around 
position 60.  Thirty-one conserved nucleotides appear in all the 25 sequences, except for 
L8 and L19, (CTTCTCCCATGCGCCGTTTGCGTTCAAAGAT). SNPs are observed on 
this region as well such as at position 65, C→A in L1 and L14 and C→G in L18, L24 
and L30. At position 66, C→A in L18, L24 and L30 and, at position 83, T→G in L9 and 
T→A in L18 and L24 were also observed.  
A block of 68 conserved nucleotides was observed between positions 107-174 in all of 
the 28 sequences. Single point variations were observed here as well. For instance, at 
position 114 T→C in L8 and L30 and T→G in L9 and at position121, A→G in L8, L9, 
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L18, L24 and A→T in L30. Furthermore, TTT →CAT at position 151 to 153 and 
TTT→AAG and AAA in L12 and L13, respectively were observed.  
Moreover, 34 conserved nucleotides 
(GGAAGCCAAGTCATCCATCGCGACACGTTATGTG) were also observed in 27 of 
the sequences with the exception of L19 between 181-214. Similar SNPs were also in this 
region. For instance, G→C in L8 and L9, G→A in L18 and L24 and G→T in L30 at 
position 181.  Also at 188-189 AA→CA in L9, and GG in L18 and L24. Also, at position 
216-218, ACA→AAA in L18 and L24. 
GCACCCCCC was found in all the sequences at 242-250 and GTATAAAC at 284-291 
and TTTTGTATATGTTTTTTTT in all the sequences at position 1167-1185 except for 
L8, L19 and L20.  
The sequences were compared to the same references as the first phylogenetic tree 
retrieved from Genbank (KJ567478, KJ567477, KJ567476, KJ567479, KJ567481, 
KJ567480 and KJ567482). The phylogenetic tree revealed the presence of four different 
clusters. Cluster I‟ consisted of L34, L7, L17, L25, L20, L13 and L31. Cluster II‟ 
consisted of all the references, in addition to L8, L1, L2, L3, L4 and L16. Cluster III‟ was 
composed of L6, L14, L9, L12, L10, L19, L30, L24 and L18. And finally, cluster IV‟ 
consisted of L15, L5, L11, L29, L26 and L27. Low boot strap values were correlated to a 
high level of heterogeneity.  
Alignment of the obtained 28 isolates also revealed three different sequence types. Based 
on the alignment, sequences L1-L7, L9-L18, L30-L31 and L34 showed significant 
similarity but with several point mutations as indicated above. Sequences L8 and L19 
showed to be distantly related from each other and from the other sequences. L8 clustered 
46 
 
distantly from the other sequences and appeared to be closely related to L. tropica and L. 
infantum reference strains (bootstrap value 98). L19 appeared to be part of the cluster III‟. 
Regarding the G+C content, both L8 and L19 revealed a significantly higher G+C 
content than the other iolates (49.41% and 52.11%, respectively).  
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Figure 14. ITS1-5.8S rDNA gene sequences alignment of L. tropica isolates using CLC Main Workbench v3.1. 
Matching residues are depicted as dot and highlighted with the same color. Gaps are denoted as dashes.   
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Matching residues are depicted as dot and highlighted with the same color. Gaps are denoted as dashes. Continued   
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Matching residues are depicted as dot and highlighted with the same color. Gaps are denoted as dashes. Continued   
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4.4. Assessing DNA quality through Actin & GAPDH amplification 
In order to rule out possible DNA quality reasons that might have caused the observed 
differences in results, two housekeeping genes, Actin and GAPDH, were amplified. 
The first PCR amplification yielded no bands. Nested PCR resulted in bands at around 60 
bp and 150 bp for Actin and GAPDH, respectively, after loading 25 uL of the PCR 
amplicon on the gel. 
All the isolates used in this study were positive for Actin and GAPDH after performing 
nested PCR. Two isolates (data not shown) proved to be negative for both of these genes 
and hence were not included in this study. 
 
 
Figure 16. Agarose gel electrophoresis of two DNA isolates (labeled L1 and L2) for the housekeeping 
genes, GAPDH and actin. Actin depicted in lanes 2 and 4 give a band size of around 50 bp;  GAPDH 
depicted in lanes 3 and 5 give a band size of around  120 bp. L1A, actin for isolate 1; L2A, actin for isolate 
2; L1G, GAPDH for isolate 1; L2G, GAPDH for isolate 2. A 100 bp ladder was used as a molecular 
marker. N: negative control. 
 
 
 
L1A  L1G  L2A  L2G   N 
100 bp 
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Chapter Five 
DISCUSSION 
The main objectives of this study were to identify the Leishmania parasites responsible 
for leishmaniasis outbreaks observed recently in Syrian refugee camps and collective 
shelters in Lebanon. Two molecular techniques were used for this purpose, ITS1 PCR-
RFLP and nested ITS1-5.8S rDNA gene PCR. Phylogenetic tree analysis based on the 
PCR products of both methods was then performed. 
5.1. DNA extraction from FFPE tissue 
DNA extraction from Leishmania-suspected FFPE skin biopsies was performed based on 
an optimized protocol according to Yehia et al (Yehia et al, 2012). Since Leishmania 
parasites only contain few ng of DNA, DNA extraction has to be highly efficient to 
obtain enough concentration for further analysis (Barker, 1989). In this study, 
commercial reagents (Qiagen GmbH) were used to extract purified DNA from FFPE skin 
biopsies. However, this method was not sufficiently efficient. Although the obtained 
DNA concentrations ranged from 8.5 ng/uL to 462.3 ng/uL (66.16 ± 99.62 ng/uL), all the 
conducted PCR reactions, including the isolates having a DNA concentration as high as 
400 ng/uL, required a second PCR to obtain a visible band, making the analysis process 
more costly, tedious and time consuming.  
Several methods have been reported previously for DNA extraction from clinical 
leishmaniasis samples. Crude DNA can be extracted from FFPE using the direct boiling 
method by incubating at 56°C, then boiling for few minutes (Safaei et al, 2002; Laskay et 
al, 1995). DNA extraction can also be performed from stained slides (Schonian et al, 
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2003; Meredith et al, 1993; Osman et al, 1998), lesion scraping on filters (Schonian et al, 
2003; Bensoussan et al, 2006; Boggild et al, 2010), promastigote cultures (van Eys et al, 
1992), fresh skin punch biopsies (Mugasa et al, 2010), bone marrow aspirates (Minodier 
et al, 1997) and blood (Boom et al, 1990; Spanakos et al, 2008).  
DNA extraction from FFPE tissue blocks was first reported in 1985 (Goelz et al, 1985). 
Since then, this method has been extensively optimized. Laskay et al (1995) extracted 
DNA from FFPE tissues using a direct boiling technique. They concluded that a DNA 
concentration corresponding to 0.1 pg of Leishmania promastigotes was sufficient for 
subsequent PCR analysis of L. aethiopica. However, this method only allowed the 
identification of 32% (7 out of 22 cases) of the suspected leishmaniasis cases (Laskay et 
al, 1995). In 2002, Safaei et al (2002) could identify 92% of suspected leishmaniasis 
cases using the same method. 
Despite these promising results, FFPE tissue storage faces several limitations. It has been 
reported that DNA often gets degraded during the process of formalin fixation as well as 
during the extraction process itself (Huijsmans et al, 2010; Momeni et al, 1996). In order 
to assess whether the observed PCR problems were linked to DNA quality, two 
housekeeping genes, Actin and GAPDH, were amplified. Similarly, the first PCR 
amplification yielded no bands. Nested PCR using the same set of primers yielded 
positive results for all the isolates used in this study. Only two isolates (data not shown) 
proved to be negative for both of these genes and hence were excluded. Therefore, the 
need to conduct nested PCR was most probably due to low DNA quality in the samples 
which can be linked to the presence of crosslinks in the extracted DNA (Ludyga et al, 
2012). 
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5.2. Leishmania typing using ITS1-PCR-RFLP and ITS1-5.8S rDNA 
gene 
Previously several studies exploited the ITS1 region amplification technique for the 
discrimination of Leishmania parasites (Shonian et al, 2003; Roelfsema et al, 2011; Amro 
et al, 2009; Hamarsheh et al, 2012). In prokaryotes, the genes coding for ribosomal RNAs 
are arranged in an operon in the following order 5‟-16S-23S-5S-3‟. These are separated 
by two spacer regions known as the Intergenic Transcribed Spacer (ITS) (Condon et al. 
1995). The ITS1 is the sequence in between the 18S rRNA and 5.8S rRNA genes. It 
contains enough conservation to serve as a PCR target but sufficient polymorphisms to 
facilitate species typing and identification (Roelfsema et al, 2011). In eukaryotes, rRNA 
genes are organized in tandem repeat units separated by a non-transcribed spacer. As 
opposed to these non-transcribed spacer regions, the combined internal transcribed 
spacers of rDNA (ITS-rDNA) in Leishmania species are considered to be relatively 
small. Also, these are often flanked by highly conserved gene segments that can be 
successfully targeted by PCR primers (Cupolillo et al., 1995). Schönian et al (2001) 
identified size polymorphisms in PCR amplified ITS regions that proved to be specific 
for certain Leishmania species. In this study, the bands obtained upon amplification of 
the ITS1 region were often faint even after nested PCR. The first PCR reaction targeted 
DNA concentration of around 0.1 pg/uL. The nested PCR reaction required a minimum 
of 10 uL of the previously obtained amplicon. Considering that previous studies reported 
a minimum of 10 pg/uL for visualization (Ajouad et al, 2014; Bensoussan et al, 2006), 
the obtained results explain the reason why the first PCR of the ITS1 region did not yield 
an amplification product. On the other hand, it was previously reported that ITS1 PCR 
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could detect 0.2 parasites per PCR assay of leishmanial DNA equivalent, when using 
filter paper spotted with peripheral blood mixed with culture promastigotes (Schonian et 
al, 2003). However, these results indicate that performing nested PCR amplicon partially 
solved the problem of poor initial DNA concentration and that initial amounts as little as 
0.1 pg of DNA can in fact be detected by PCR- based molecular typing techniques 
(Schonian et al, 2003). 
Nested ITS1-5.8S rDNA gene PCR enhanced the sensitivity of this diagnostic tool by 
targeting two fragments in the ITS-rDNA region one region consisting of ITS1 with the 
5.8S rDNA gene (Parvizi and Ready, 2008). In this study, the first PCR reaction similarly 
targeted a DNA concentration of around 0.1 pg/uL. Also, no bands were obtained during 
the first PCR reaction. However, for the nested PCR reaction, only a minimum of 2 uL of 
the original PCR amplicon were needed to obtain a good yield. These results suggest that 
the nested PCR of ITS1-5.8S rDNA gene is more sensitive for Leishmania species 
identification. Indeed, the ITS1-5.8S rDNA gene PCR that was able to identify L. tropica 
in 70% of the isolates as opposed to only 47.4 % identified by the ITS1-PCR method. 
This proved to be consistent with a number of previously obtained results (el Tai et al, 
2000; el Tai et al, 2001; Spanakos et al, 2008; Schallig et al, 2002; Parvizi et al, 2008; Es-
Sette et al, 2014). In fact, this PCR approach has been employed in the detection of 
Leishmania in entomological surveys (Ajouad et al, 2013). No clear-cut correlation was 
observed between the results of the PCR assays and the time of evolution of the 
cutaneous lesions. 
Moreover, ITS1 PCR-RFLP is the most widely used assay for direct detection and 
identification of Leishmania species in the Old World (Schonian et al, 2011). In this 
56 
 
study, RFLP of the ITS1 PCR product revealed that the isolates belonged to the L. 
tropica (Schonian et al, 2001; Schonian et al, 2003; Doudi et al, 2010; Rotureau et al, 
2006; Al Nahhas and Kalda, 2013). It is worth noting that previous attempts of extending 
the RFLP fragment to include the 5.8S rDNA gene region did not show any advantage 
(Parvizi and Ready, 2008). RFLP proved to be successful in the distinction of sympatric 
species, especially in the Mediterranean region, as well as for the identification of 
imported cases of leishmaniasis due to population migrations such as those associated 
with war (Harms et al, 2003; Al-Jawabreh et al, 2004; Rhajaoui et al. 2007).  
5.3. Sequencing and phylogenetic tree analysis of haplotype sequences of 
Leishmania ITS-rDNA 
Although the ITS region serves as a marker for the differentiation of Leishmania at both 
the species and the strain levels, only few studies employed ITS sequence analysis to 
compare L. tropica isolates (Schonian et al, 2001; Khanra et al, 2011; Talmi-Frank et al, 
2010; Mahdy et al, 2010; Bosslimi et al, 2012; Ghatee et al, 2014). In this study, 
sequencing of the obtained PCR products of both PCR reactions, targeting the ITS1 and 
the ITS1-5.8S rDNA gene regions was performed. Sequences were compared to four L. 
tropica and three L. infantum reference strains (Es Sette et al, 2014).  
L. tropica is known to be a very heterogenous species (Azmi et al, 2012; Shonian et al, 
2001; Le Blancq et al, 1986) and this was clearly observed in the alignment of the ITS1-
PCR amplification products and the low bootstrap values obtained on the phylogenetic 
tree. The reason behind this is the occurrence of at least two alleles for ITS in ribosomal 
DNA in Leishmania spp. (Ghatee et al, 2013; Mauricio et al, 2004). Alignment based on 
the ITS1-5.8S rDNA gene revealed a significantly higher level of conservation than the 
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ITS1 based alignment. In both cases, the sequences were separated into three different 
sequence types though accommodating different isolates. Also, the topology of both trees 
revealed that references were joined in a single clade. The separate clustering of the 
references was also reported in previous studies (Mahdy et al, 2010; Es-Sette et al, 2014).   
It is commonly reported that samples positive for leishmaniasis often show unreadable 
sequences upon ITS-rDNA fragment examination (Mirzaei et al, 2013). This can be 
explained by extremely high heterogeneity levels or sometimes may be due to mixed 
infections of two or more Leishmania species (Mirzaei et al, 2013; Parvizi et al, 2008; 
Parvizi et al, 2008; Strelkova et al, 2001)..  
 
In this study, two techniques for the molecular detection of Leishmania isolates were 
used: ITS1-PCR RFLP and ITS1-5.8S rDNA gene PCR amplification.  ITS1-PCR RFLP 
profiles proved that the obtained isolates were all L. tropica. This was further validated 
by sequencing the ITS1-PCR product as well as the ITS1-5.8S rDNA gene product. 
ITS1-5.8S rDNA PCR proved to be a more sensitive identification method for 
Leishmania isolates. A high level of heterogeneity was revealed in the obtained 
sequences.  The outbreaks of leishmaniasis in Lebanon are hypothesized to be caused by 
the migration of Syrian refugees. This hypothesis is confirmed by the fact that Syria 
shows high levels of CL infections. Leishmaniasis outbreaks were reported in many 
Syrian cities, including Aleppo (Desjeux, 2004). Unfortunately, vaccination against 
Leishmania has shown many drawbacks (Murray et al, 2005). So far, no vaccines or 
drugs to prevent infection are available (CDC, 2013). 
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The molecular typing of Leishmania will continue using accurate clinical microbiology 
typing techniques in order to get a better understanding of this parasite and have 
sufficient information for the subsequent development of new vaccines or other more 
efficient preventative methods. 
For the differentiation of Leishmania at the sub-species level, it is recommended to 
perform multi-locus sequence typing (MLST) method. Moreover, whole-genome 
sequencing (WGS), also referred to as next-generation sequencing (NGS), provides a 
greater potential to identify genetic component of health problems and infectious 
diseases. The massive amount of data generated from WGS can reveal disease-causing 
alleles that could not be detected otherwise such as virulence drug-resistance, etc. (Gvan 
et al, 2013). Thus, it can be used for further in-depth study of the epidemiology, evolution 
and pathogenomics of Leishmania (Schonian et al, 2011).   
To achieve better DNA quality and quantity it is recommended to try a commercial FFPE 
DNA extraction kit designed to remove cross links. Also, it would be of interest to type 
Leishmania isolated from sand fly vectors. Furthermore, accessible international 
databases for cases of leishmaniasis should be created for a better epidemiological 
assessment of these infectious agents and for tracing their patterns of migration between 
countries and continents. Better cooperation between laboratory scientists, 
epidemiologists, clinicians, veterinarians and public health authorities is needed, as well, 
in order to create a surveillance program of leishmaniasis.   Finally, international 
collaboration under the supervision of the World Health Organization (WHO) is 
necessary for controlling the spread of leishmaniasis. 
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Chapter Six 
CONCLUSION 
 
In conclusion, the use of ITS1-PCR RFLP and ITS1-5.8S rDNA gene PCR enabled the 
accurate detection and identification of L. tropica in FFPE clinical samples. ITS1-5.8S 
rDNA gene PCR proved to be a more sensitive method for Leishmania spp. discrimination. 
The obtained results highlight the need to find a universally accepted diagnostic tool for 
Leishmania typing, that is specific, sensitive, rapid and capable of identifying all 
clinically significant Leishmania species. Also, it was demonstrated that L. tropica is the 
causative agent of leishmaniasis outbreaks observed among Syrian refugees that are 
seeking shelter in the Lebanon. The living conditions in refugee‟s camps and collective 
shelters are characterized by poor sanitary conditions and inadequate waste disposal, thus 
increasing the risk of Leishmania transmission through the sand-fly vector. 
Unfortunately, children of less than 10 years old are the most affected (Alawiyeh et al, 
2014). The risk of transmitting this “flesh-eating” parasite into the Lebanese community 
is high. Thus, effective prevention methods and appropriate therapy is critical. Prevention 
can be as simple as using nets treated with insecticide or spraying insecticides to kill 
sand-fly vectors (Barret et al, 2012). 
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ANNEX I 
 
Table. Biotype numbers, isolate names, location where the samples were collected, the duration of the 
lesions (in months), patient age (in years) and gender (M: male; F: female) of all the tissue samples 
assessed in this study.  
 Biotype Isolate 
Name 
Location Date of Lesion 
(months) 
Age Gender 
1 HH-13-10 L1 Beirut 4 6 F 
2 HH-13-11 L2 Beirut 4 21 M 
3 HH-13-12 L3 Beirut 4 31 F 
4 HH-13-14 L4 Beirut 5 25 F 
5 HH-13-16 L5 Beirut 6 25 M 
6 HH-13-17 L6 Beirut 5 5 M 
7 ZA-13-5 L7 Zahle 2 10 F 
8 ZA-13-6 L8 Zahle 5 5 M 
9 ZA-13-8 L9 Zahle 2 9 M 
10 ZA-13-10 L10 Zahle 5.5 5 M 
11 ZA-13-11 L11 Zahle 6 1 M 
12 ZA-13-13 L12 Zahle 7 3 F 
13 AK1 L13 Akkar 5 9 F 
14 AK2 L14 Akkar 4 12 F 
15 AK5 L15 Akkar 3 4 F 
16 1-HH L16 Beirut 4 34 F 
17 4-HH L17 Beirut 4 4 M 
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18 S13-60-1A L18 Akkar 3 11 F 
19 S13-193-
1A 
L19 Akkar 2.5 74 F 
20 AK13-13 L20 Akkar 5 42 F 
21 D02-727A L24 Beirut 3 37 M 
22 D02-727B L25 Beirut 4 9 F 
23 D04-228 L26 Beirut 3 54 F 
24 D05-536 L27 Beirut 1 13 F 
25 D08-154 L29 Beirut 4 18 M 
26 D08-1029 L30 Beirut 3 83 M 
27 D08-1030 L31 Beirut 3 83 F 
28 D10-533 L34 Beirut 6 83 F 
29 D93-194 L39 Beirut 3 60 F 
30 D93-470 L41 Beirut 4 53 F 
31 D94-247 L42 Beirut 12 16 M 
32 D94-270 L43 Beirut 3 46 F 
33 D95-157 L44 Beirut 4 46 M 
34 D95-494 L45 Beirut 12 5 M 
35 10345 L62 Aleppo 3 11 F 
36 11469 L63 Aleppo 2 65 F 
37 28636 L67 Saida ( 
HA) 
3 4 M 
38 52536 L68 Saida ( 
HA) 
7 23 M 
39 P11-26000 L69 Saida ( 
HA) 
9 72 F 
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40 4HH L70 Beirut 4 4 M 
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ANNEX II 
 
Table. DNA concentrations and purities obtained after performing DNA extraction on the 40 extracted 
Leishmania isolates (as measured by the NanoDrop Spectrophotometer and by Qubit).  
  Isolate Name NanoDrop (ng/uL) Purity Qubit(ng/uL) 
1 L1 37.6 1.39 Too low 
2 L2 41.7 1.77 1.76 
3 L3 31.2 1.34 2.38 
4 L4 48.3 1.43 1.63 
5 L5 31.7 1.47 2.24 
6 L6 35.2 1.66 2.23 
7 L7 45.3 1.65 1.19 
8 L8 82.7 1.45 2.93 
9 L9 53.7 1.25 1.34 
10 L10 37.7 1.63 1.27 
11 L11 40.6 1.93 1.69 
12 L12 71 1.91 12 
13 L13 46 1.93 1.94 
14 L14 41.5 1.8 Too low 
15 L15 34.5 1.41 3.5 
16 L16 21.9 1.36 Too low 
17 L17 34.8 1.37 3.74 
18 L18 61.1 1.37 1.83 
19 L19 26.1 1.3 Too low 
20 L20 20.2 1.57 1.37 
21 L24 41.6 1.76 ? 
22 L25 462.3 1.83 15.9 
23 L26 16.5 . Too low 
24 L27 8.5 . 1.24 
25 L29 8.8 2.01 Too low 
26 L30.1 129.1 2.14 ? 
27 L30.2 19.1 2.36 4.92 
28 L34 460.7 1.98 7.2 
29 L39 31.4 3.74 0.97 
30 L41 14.4 . 0.2 
31 L42 86.4 2.14 1.17 
32 L43 137.8 2.46 4.44 
33 L44 35 3.92  10.11 
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34 L45 48.7 2.58  12.13 
35 L62 28.6 7.24 2 
36 L63 209.1 2.05 28.5 
37 L67 16.9 . Too low 
38 L68 12.6 . 0.992 
39 L69 13.8 . 0.572 
40 L70 22.3 . 1.06 
 
 
